DarioHealth Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on November 15, 2019, reporting events occurring on November 14, 2019. DarioHealth Corp., a Delaware corporation, announced the implementation of a reverse stock split and the elimination of a series of preferred stock.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: A one-for-twenty reverse stock split was approved by the Board of Directors and authorized by stockholders. It became effective at 12:01 a.m. EST on November 18, 2019.
- Share Count Adjustment: As of November 14, 2019, there were 43,696,840 shares of common stock outstanding. Post-split, the outstanding share count is approximately 2,184,842 shares.
- Trading Details: The stock continues to trade on the Nasdaq Capital Market under the symbol "DRIO" but with a new CUSIP Number (23725P 209).
- Fractional Shares: No fractional shares were issued; shareholders entitled to fractions received one additional whole share.
- Preferred Stock: The Company filed a Certificate of Elimination to remove the Series D Convertible Preferred Stock from its Certificate of Incorporation. No shares of this series were outstanding.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that shareholder percentage ownership remains virtually unchanged except for minor rounding adjustments.
Investor Verification Checklist
- Confirm the new CUSIP Number (23725P 209) for trading purposes.
- Verify the adjusted number of shares held in brokerage accounts post-November 18, 2019.
- Check for adjustments to the exercise price and share count of any outstanding options, warrants, or convertible securities.
- Review the impact of the reduced share count on the company's ability to meet Nasdaq listing requirements.